Clinical trial Recruiting at 1 site Observational Ages 18 and up

Survey on long-term use of AJOVY for migraine treatment

Official title: AJOVY Subcutaneous Injection Long-term Specified Use-results Survey

Run by Otsuka Pharmaceutical Co., Ltd. · NCT05342493 · Data updated 2026-11-12

This study is looking to see how safe AJOVY is for people using it to treat migraines over a long time, especially regarding heart-related issues.

More Migraine Disorders trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorOtsuka Pharmaceutical Co., Ltd.
Industry-sponsored
Locations1 site (Osaka)
StatusRecruiting
StartedApril 20, 2022
Main results expectedSeptember 30, 2026
Study endsJune 22, 2029
Registry record updatedJune 22, 2026
Trial IDNCT05342493 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients with migraine disorders who are currently using AJOVY.

Probably not a fit

Patients with known hypersensitivity to components of AJOVY will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the long-term safety of AJOVY, a medication for migraine disorders, in real-world settings. It will specifically assess cardiovascular events associated with its use while also collecting information on the drug's efficacy. The study will involve patients who are currently using AJOVY to gather data on its effects over time.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term safety and effectiveness of AJOVY for migraine patients.

How similar studies have gone: Other studies evaluating long-term safety of migraine treatments have shown promising results, suggesting that this approach is relevant and potentially beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\-

Exclusion Criteria:

* patients with a known hypersensitivity to components of AJOVY

Where it's running

  • Pharmacovigilance Department
    Osaka, Japan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry

    This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.

    Recruiting Association of Migraine Disorders · North Kingstown, Rhode Island · NCT07754266

  • MMA Embolization for Migraine: Patient-Reported Outcomes from a Single Site

    This registry tests whether adults with migraine who have or plan to have middle meningeal artery embolization notice changes in headaches and quality of life over time.

    Recruiting Cortex Neurovascular · Tacoma, Washington · NCT07652034

  • Greater Occipital Nerve Block for Migraine with Medication Overuse Headache

    This study will test whether a nerve block using lidocaine and methylprednisolone can help people with migraine who overuse medications to reduce withdrawal headaches during detoxification.

    Recruiting at 2 sites Mahidol University · Bangkok, Bangkok and 2 other locations · NCT07568496

  • Closing a PFO to improve glymphatic function and migraine symptoms

    This study will see if closing a patent foramen ovale (PFO) improves glymphatic system function and reduces migraine attacks in adults with PFO and migraine.

    Recruiting at 2 sites First Affiliated Hospital Xi'an Jiaotong University · Luoyang, Henan and 1 other locations · NCT07170176

  • Italian Migraine Registry (I-GRAINE-NEW)

    This registry will collect past and future clinical and healthcare data from adults with episodic or chronic migraine who come to specialized headache centers in Italy to better understand how the condition evolves and is treated.

    Recruiting IRCCS San Raffaele Roma · Roma, Roma · NCT07163416

  • Topical cannabidiol (Canvert-M) for migraine attacks

    This will test whether applying Canvert-M, a topical roll-on with cannabidiol and essential oils, can reduce pain during migraine attacks in adults aged 18–55.

    Recruiting Phase 4 Alasht Pharmed · Tehran · NCT07093138

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.